{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:48:17Z","timestamp":1761922097097,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":227,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ijpddr.2012.03.003","type":"journal-article","created":{"date-parts":[[2012,4,14]],"date-time":"2012-04-14T09:08:17Z","timestamp":1334394497000},"page":"121-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Pharmacokinetics of the fasciocidal drug candidates MT04 and OZ78 in uninfected rats and in vitro pharmacodynamic studies"],"prefix":"10.1016","volume":"2","author":[{"given":"Carla","family":"Kirchhofer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Huwyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2012.03.003_b0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/bdd.353","article-title":"Impact of solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male wistar rats","volume":"24","author":"Bittner","year":"2003","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0010","article-title":"Evaluation of the pharmacokinetic profile of artesunate, artemether and their metabolites in sheep naturally infected with Fasciola hepatica","author":"Duthaler","year":"2011","journal-title":"Vet. Parasitol"},{"key":"10.1016\/j.ijpddr.2012.03.003_b0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/tvjl.1999.0377","article-title":"Fasciolicides: efficacy, actions, resistance and its management","volume":"158","author":"Fairweather","year":"1999","journal-title":"Vet. J."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vetpar.2011.05.034","article-title":"Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy?","volume":"180","author":"Fairweather","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0125","article-title":"FDA Guidance for Industry Bioanalytical Method Validation, Food and Drug Administration","author":"FDA","year":"2001","journal-title":"Center for Drug Evaluation and Research (CDER)"},{"key":"10.1016\/j.ijpddr.2012.03.003_b0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(11)70294-8","article-title":"Global burden of human food-borne trematodiasis: a systematic review and meta-analysis","volume":"12","author":"F\u00fcrst","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0035","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1371\/journal.pmed.0030102","article-title":"Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, and malaria","volume":"3","author":"Hotez","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0040","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1517\/13543784.14.12.1513","article-title":"Triclabendazole for the treatment of fascioliasis and paragonimiasis","volume":"14","author":"Keiser","year":"2005","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.ijpddr.2012.03.003_b0045","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/jac\/dkl408","article-title":"The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica","volume":"58","author":"Keiser","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.pt.2007.07.012","article-title":"Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes","volume":"23","author":"Keiser","year":"2007","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.exppara.2007.12.015","article-title":"Fasciola hepatica: Surface tegumental responses to in vitro and in vivo treatment with the experimental fasciolicide OZ78","volume":"119","author":"Keiser","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00436-008-0998-0","article-title":"Efficacy and safety of artemether against a natural Fasciola hepatica infection in sheep","volume":"103","author":"Keiser","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jac\/dkn550","article-title":"Pharmacokinetic parameters of artesunate and dihydroartemisinin in rats infected with Fasciola hepatica","volume":"63","author":"Keiser","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.vetpar.2010.06.031","article-title":"Efficacy, safety and pharmacokinetics of 1,2,4-trioxolane OZ78 against an experimental infection with Fasciola hepatica in sheep","volume":"173","author":"Keiser","year":"2010","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0075","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.jchromb.2010.08.020","article-title":"Development and validation of a liquid chromatography\/mass spectrometry method for pharmacokinetic studies of OZ78, a fasciocidal drug candidate","volume":"878","author":"Kirchhofer","year":"2010","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.actatropica.2011.02.003","article-title":"Activity of OZ78 analogues against Fasciola hepatica and Echinostoma caproni","volume":"118","author":"Kirchhofer","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0085","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ijpara.2005.07.010","article-title":"Fascioliasis and other plant-borne trematode zoonoses","volume":"35","author":"Mas-Coma","year":"2005","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0090","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1098\/rstb.2009.0089","article-title":"Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases","volume":"364","author":"Robinson","year":"2009","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0095","doi-asserted-by":"crossref","first-page":"e1000255","DOI":"10.1371\/journal.pmed.1000255","article-title":"Which new approaches to tackling neglected tropical diseases show promise?","volume":"7","author":"Spiegel","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijpddr.2012.03.003_b0100","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02779","article-title":"Identification of an antimalarial synthetic trioxolane drug development candidate","volume":"430","author":"Vennerstrom","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2012.03.003_b0105","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1021\/jm100226t","article-title":"Structure\u2013activity relationship of an ozonide carboxylic acid (OZ78) against Fasciola hepatica","volume":"53","author":"Zhao","year":"2010","journal-title":"J. Med. Chem."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320712000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320712000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:45:05Z","timestamp":1761921905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320712000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":21,"alternative-id":["S2211320712000140"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2012.03.003","relation":{},"ISSN":["2211-3207"],"issn-type":[{"type":"print","value":"2211-3207"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of the fasciocidal drug candidates MT04 and OZ78 in uninfected rats and in vitro pharmacodynamic studies","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2012.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Australian Society for Parasitology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}